Clinical Trial Update: Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens [Phase 3]

View source ↗

Summary

Phase 3 clinical evaluation of the Lenstec SBL-3 multifocal intraocular lens has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataracts
• Presbyopia

Drugs mentioned

• Lenstec SBL-3 multifocal intraocular lens (intraocular lens)

Snippet

Sponsor: Lenstec Incorporated | Conditions: Cataracts, Presbyopia | Phase 3 | Status: COMPLETED